NO140381C - Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner

Info

Publication number: NO140381C
Authority: NO; Norway
Prior art keywords: arylpiperazines; preparation; therapeutically active; analogical procedure; analogical
Prior art date: 1972-12-23

Application number

NO4936/73A

Other languages

English (en)

Norwegian (no)

Other versions

NO140381B (no

Inventor

Ernst-Otto Renth

Anton Mentrup

Kurt Schromm

Peter Danneberg

Original Assignee

Boehringer Sohn Ingelheim

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-12-23

Filing date

1973-12-21

Publication date

1979-08-22

1973-12-21 Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim

1979-05-14 Publication of NO140381B publication Critical patent/NO140381B/no

1979-08-22 Publication of NO140381C publication Critical patent/NO140381C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Obesity (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Hematology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Hydrogenated Pyridines (AREA)
Pyrrole Compounds (AREA)

NO4936/73A 1972-12-23 1973-12-21 Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner NO140381C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE2263211A DE2263211A1 (de)	1972-12-23	1972-12-23	Neue arylpiperazine und verfahren zu ihrer herstellung

Publications (2)

Publication Number	Publication Date
NO140381B NO140381B (no)	1979-05-14
NO140381C true NO140381C (no)	1979-08-22

Family

ID=5865328

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO4936/73A NO140381C (no)	1972-12-23	1973-12-21	Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner

Country Status (15)

Country	Link
US (1)	US3941789A (fr)
JP (4)	JPS4994688A (fr)
AT (1)	AT338271B (fr)
BE (1)	BE809041A (fr)
CH (10)	CH605872A5 (fr)
DE (1)	DE2263211A1 (fr)
ES (10)	ES421751A1 (fr)
FI (1)	FI59990C (fr)
FR (1)	FR2211252B1 (fr)
GB (1)	GB1456253A (fr)
IE (1)	IE38679B1 (fr)
LU (1)	LU69064A1 (fr)
NL (1)	NL7317469A (fr)
NO (1)	NO140381C (fr)
SE (1)	SE417516B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4075208A (en) *	1972-08-24	1978-02-21	Ciba-Geigy Corporation	1-Substituted-4-(2-oxo-hexahydro-1-pyrimidinyl)-piperidine
US4038279A (en) *	1972-12-23	1977-07-26	Boehringer Ingelheim Gmbh	N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof
US4100282A (en) *	1972-12-23	1978-07-11	Boehringer Ingelheim Gmbh	N-Aryl-N'-(phenyl- or phenoxy-alkyl)-piperazines and salts thereof
US4440774A (en) *	1975-03-03	1984-04-03	Merck & Co., Inc.	3-Amino-2-hydroxypropoxyaryl imidazole derivatives
GB1518559A (en) *	1976-04-12	1978-07-19	Science Union & Cie	Naphthyl derivatives processes for their preparation an pharmaceutical compositions containing them
US4052399A (en) *	1976-09-13	1977-10-04	Morton-Norwich Products, Inc.	1-[2-(Hexahydro-1H-azepino)ethyl]-2(1H)pyrimidone dihydrochloride
US4052400A (en) *	1976-10-29	1977-10-04	Morton-Norwich Products, Inc.	Hypertensive 1-substituted 2(1h)-pyrimidones
EP0005828B1 (fr) *	1978-06-06	1981-03-11	Hoechst Aktiengesellschaft	Nouvelles dérivés de la phénylpipérazine substitués, médicaments les contenant et procédés pour leur préparation
DE2834114A1 (de) *	1978-08-01	1980-02-14	Schering Ag	Polyalkoxyphenylpyrrolidone iii, verfahren zu ihrer herstellung und ihre verwendung
DE3005287A1 (de) *	1980-02-13	1981-08-20	Basf Ag, 6700 Ludwigshafen	Phenylpiperazinderivate von 1,3,4-oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel
DE3101456A1 (de)	1981-01-19	1982-09-02	Basf Ag, 6700 Ludwigshafen	Phenylpiperazinyl-propanole von hetarylphenolen, ihre herstellung und diese enthaltende therapeutische mittel
DE3101502A1 (de) *	1981-01-19	1982-08-26	Basf Ag, 6700 Ludwigshafen	Phenylpiperazinderivate von hetarylphenolen und hetarylanilinen, ihre hersttellung und diese enthaltendetherapeutische mittel
CH653021A5 (fr) *	1981-04-24	1985-12-13	Delalande Sa	Derives piperidino, piperazino et homopiperazino, n-substitues par un groupe heterocyclique aromatique, leur procede de preparation et composition therapeutique les contenant.
US4367335A (en) *	1981-08-03	1983-01-04	Mead Johnson & Company	Thiazolidinylalkylene piperazine derivatives
US4450272A (en) *	1982-05-06	1984-05-22	American Cyanamid Company	Antiatherosclerotic 1-piperazine-thicarboxamides
US4452798A (en) *	1982-06-22	1984-06-05	Warner-Lambert Company	1-Substituted phenyl-4-alkyl hydantoin piperazine compounds as antihypertensive agents
EP0138754B1 (fr) *	1983-08-15	1988-05-25	Ciba-Geigy Ag	Compositions photodurcissables
US4593039A (en) *	1984-04-02	1986-06-03	Merck & Co., Inc.	1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4616017A (en) *	1984-06-04	1986-10-07	Merck & Co., Inc.	Aminohydroxypropoxy substituted aryl compounds
US4539318A (en) *	1984-06-04	1985-09-03	Merck & Co., Inc.	Tertiary aminohydroxypropoxy substituted thiadiazoles, pharmaceutical compositions and use
DE3424685A1 (de) *	1984-07-05	1986-02-06	Beiersdorf Ag, 2000 Hamburg	Neue substituierte phenylpiperazinyl-propanole, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
GB8603120D0 (en) *	1986-02-07	1986-03-12	Pfizer Ltd	Anti-dysrhythmia agents
US4732895A (en) *	1986-05-02	1988-03-22	American Cyanamid Company	α-[5-methyl-2-(pyridinyl)-1H-imidazol-4-yl]substituted-1-piperazineethanols useful for treating hypertension
WO1988003136A1 (fr) *	1986-10-27	1988-05-05	Yoshitomi Pharmaceutical Industries, Ltd.	Composes de piperazine et leur utilisation medicinale
DE3803860A1 (de) *	1988-02-09	1989-08-17	Basf Ag	N,n'-disubstituierte piperazine
US5364849A (en) *	1989-04-22	1994-11-15	John Wyeth & Brother, Limited	1-[3 or 4-[1-[4-piperazinyl]]-2 arylpropionyl or butryl]-heterocyclic derivatives
US5382583A (en) *	1989-04-22	1995-01-17	John Wyeth & Brother, Limited	Piperazine derivatives
US5166148A (en) *	1990-07-09	1992-11-24	The Du Pont Merck Pharmaceutical Company	2-amino-1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
SK283420B6 (sk) *	1992-05-08	2003-07-01	Pharmacia & Upjohn Company	Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
DK148392D0 (da) *	1992-12-09	1992-12-09	Lundbeck & Co As H	Heterocykliske forbindelser
WO1994018172A1 (fr) *	1993-02-01	1994-08-18	Yoshitomi Pharmaceutical Industries, Ltd.	Compose d'imidazolylbenzene et son utilisation comme medicament
IL114027A (en)	1994-06-08	1999-11-30	Lundbeck & Co As H	4-Phenyl piperazine (piperidine or tetrahydropyridine) derivatives serotinin 5-HT1A and dopamin D2 receptor ligand pharmaceutical compositions containing them
JP3948744B2 (ja) *	1994-11-04	2007-07-25	大日本住友製薬株式会社	新規なラクタム誘導体
CA2250347C (fr) *	1996-03-29	2006-02-21	Duphar International Research B.V.	Composes de piperazine et piperidine ayant une haute affinite pour les recepteurs de dopamine-d2 et de serotonine-5ht1a
JP4349320B2 (ja)	2005-05-12	2009-10-21	パナソニック株式会社	マニピュレータ型ロボット
WO2007048595A1 (fr) *	2005-10-27	2007-05-03	Ucb Pharma, S.A.	Composés comprenant un lactame ou un groupement dérivé de lactame, procedes de fabrication de ceux-ci, et leurs utilisations
US10126380B2 (en) *	2015-06-15	2018-11-13	Norell, Inc.	Closure and system for NMR sample containers with a secondary locking seal
CN114634479B (zh) *	2020-12-16	2025-02-07	北京盈科瑞创新药物研究有限公司	一种派嗪衍生物、其制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL127797C (fr) *	1961-02-08
US3562277A (en) *	1967-09-06	1971-02-09	Shulton Inc	Ketonic derivatives of phenyl piperazines
BE788280A (fr) *	1971-09-04	1973-02-28	Pfizer	Nouvelles 1-(3-trifluoro-methyl-phenyl)-4-((amido cyclique)- alkyl) piperazines et composition pharmaceutique les contenant

1972
- 1972-12-23 DE DE2263211A patent/DE2263211A1/de not_active Withdrawn
1973
- 1973-12-20 GB GB5919473A patent/GB1456253A/en not_active Expired
- 1973-12-20 NL NL7317469A patent/NL7317469A/xx not_active Application Discontinuation
- 1973-12-20 CH CH1790773A patent/CH605872A5/xx not_active IP Right Cessation
- 1973-12-20 FI FI3940/73A patent/FI59990C/fi active
- 1973-12-21 LU LU69064A patent/LU69064A1/xx unknown
- 1973-12-21 US US05/427,367 patent/US3941789A/en not_active Expired - Lifetime
- 1973-12-21 NO NO4936/73A patent/NO140381C/no unknown
- 1973-12-21 JP JP49004699A patent/JPS4994688A/ja active Pending
- 1973-12-21 FR FR7346112A patent/FR2211252B1/fr not_active Expired
- 1973-12-21 AT AT1072773A patent/AT338271B/de not_active IP Right Cessation
- 1973-12-21 BE BE139227A patent/BE809041A/fr not_active IP Right Cessation
- 1973-12-21 SE SE7317423A patent/SE417516B/xx unknown
- 1973-12-22 ES ES421751A patent/ES421751A1/es not_active Expired
- 1973-12-28 IE IE2338/73A patent/IE38679B1/xx unknown
1976
- 1976-01-29 ES ES444735A patent/ES444735A1/es not_active Expired
- 1976-01-29 ES ES444733A patent/ES444733A1/es not_active Expired
- 1976-01-29 ES ES444736A patent/ES444736A1/es not_active Expired
- 1976-01-29 ES ES444730A patent/ES444730A1/es not_active Expired
- 1976-01-29 ES ES444738A patent/ES444738A1/es not_active Expired
- 1976-01-29 ES ES444731A patent/ES444731A1/es not_active Expired
- 1976-01-29 ES ES444737A patent/ES444737A1/es not_active Expired
- 1976-01-29 ES ES444732A patent/ES444732A1/es not_active Expired
- 1976-01-29 ES ES444734A patent/ES444734A1/es not_active Expired
1977
- 1977-12-09 CH CH1517077A patent/CH616669A5/de not_active IP Right Cessation
- 1977-12-09 CH CH1517377A patent/CH616675A5/de not_active IP Right Cessation
- 1977-12-09 CH CH1516777A patent/CH616673A5/de not_active IP Right Cessation
- 1977-12-09 CH CH1516977A patent/CH616668A5/de not_active IP Right Cessation
- 1977-12-09 CH CH1517577A patent/CH616677A5/de not_active IP Right Cessation
- 1977-12-09 CH CH1517177A patent/CH616670A5/de not_active IP Right Cessation
- 1977-12-09 CH CH1516877A patent/CH616667A5/de not_active IP Right Cessation
- 1977-12-09 CH CH1517277A patent/CH616674A5/de not_active IP Right Cessation
- 1977-12-09 CH CH1517477A patent/CH616676A5/de not_active IP Right Cessation
1983
- 1983-07-15 JP JP58129263A patent/JPS5976074A/ja active Pending
- 1983-07-15 JP JP58129262A patent/JPS5976067A/ja active Pending
- 1983-07-15 JP JP58129261A patent/JPS5976070A/ja active Pending

Also Published As

Publication number	Publication date
US3941789A (en)	1976-03-02
CH616677A5 (fr)	1980-04-15
IE38679L (en)	1974-06-23
CH616673A5 (fr)	1980-04-15
ES444730A1 (es)	1977-05-16
BE809041A (fr)	1974-06-21
FR2211252B1 (fr)	1977-01-28
JPS5976070A (ja)	1984-04-28
ES444733A1 (es)	1977-05-16
CH616670A5 (fr)	1980-04-15
NL7317469A (fr)	1974-06-25
FR2211252A1 (fr)	1974-07-19
ATA1072773A (de)	1976-12-15
AT338271B (de)	1977-08-10
CH616675A5 (fr)	1980-04-15
CH616674A5 (fr)	1980-04-15
CH616667A5 (fr)	1980-04-15
ES444737A1 (es)	1977-05-16
DE2263211A1 (de)	1974-07-04
CH616676A5 (fr)	1980-04-15
NO140381B (no)	1979-05-14
IE38679B1 (en)	1978-05-10
AU6397773A (en)	1975-07-03
FI59990B (fi)	1981-07-31
ES444738A1 (es)	1977-05-16
LU69064A1 (fr)	1975-08-20
CH605872A5 (fr)	1978-10-13
FI59990C (fi)	1981-11-10
CH616669A5 (fr)	1980-04-15
ES444735A1 (es)	1977-05-16
ES421751A1 (es)	1976-12-16
ES444736A1 (es)	1977-05-16
SE417516B (sv)	1981-03-23
GB1456253A (en)	1976-11-24
ES444732A1 (es)	1977-05-16
ES444734A1 (es)	1977-05-16
CH616668A5 (fr)	1980-04-15
JPS5976067A (ja)	1984-04-28
JPS4994688A (fr)	1974-09-09
ES444731A1 (es)	1977-05-16
JPS5976074A (ja)	1984-04-28

Publication	Publication Date	Title
NO140381C (no)	1979-08-22	Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO138335C (no)	1978-08-16	Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
NO139560C (no)	1979-04-04	Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
NO136837C (no)	1977-11-16	Analogifremgangsm}te for fremstilling av terapeutisk aktive pleuromutiliner
NO137694C (no)	1978-04-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO138565C (no)	1978-09-27	Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO138566C (no)	1978-09-27	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NO140058C (no)	1979-07-04	Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO138999C (no)	1978-12-20	Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO142033C (no)	1980-06-18	Analogifremgangsmaate for fremstilling av nye terapeutisk aktive isopropylamino-3-fenoksypropanoler
NO137782C (no)	1978-04-26	Analogifremgangsmaate for fremstilling av nye farmakologisk aktive amino-fenyl-etanolaminer
NO140977C (no)	1979-12-19	Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner
NO137824C (no)	1978-05-03	Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylalkyltetrazoler
NO137899C (no)	1978-05-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider
NO137858C (no)	1978-05-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO140670C (no)	1979-10-17	Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO139088C (no)	1979-01-03	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner
NO138025C (no)	1978-06-14	Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler
NO138026C (no)	1978-06-14	Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner
NO138063C (no)	1978-06-21	Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater
NO137728C (no)	1978-04-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO137151C (no)	1978-01-11	Analogifremgangsm}te for fremstilling av terapeutisk aktive ortiotropin-peptider
NO138251C (no)	1978-08-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer
NO139050C (no)	1979-01-03	Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater
NO137727C (no)	1978-04-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-hydroksy-3-metyltriazener